Ligand Pharmaceuticals (LGND) total debt

Total debt · fiscal 2025
$451.49M

Ligand Pharmaceuticals (LGND) carried total debt of $451.49M at the end of fiscal 2025 (December 31, 2025). That is 6276.1% higher than the $7.08M of fiscal 2024. Figures as of 18 Nov 2026, 07:39 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$451.49M
Change on fiscal 2024
+6276.1%
Highest on record
$451.49Mfiscal 2025
Lowest on record
$6.17Mfiscal 2023
Fiscal years on record
52012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Ligand Pharmaceuticals total debt, in more detail

Across the 5 fiscal years on record (2012–2025), the highest was $451.49M in fiscal 2025 and the lowest $6.17M in fiscal 2023.

Total debt was 0.4× shareholders' equity at the end of fiscal 2025.

History · 5 fiscal years

Total debt by fiscal year

Ligand Pharmaceuticals total debt, year by year

Ligand Pharmaceuticals (LGND) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$451.49M 6,276.1% up0.4×
2024$7.08M 14.9% up0.0×
2023$6.17M 93.0% down0.0×
2022$87.75M—0.1×
2012$27.50M—1.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Ligand Pharmaceuticals and comparable companies
CompanyTotal debtFiscal year
Ligand Pharmaceuticals LGND$451.49M2025
Scholar Rock Holding SRRK$108.92M2025
Teleflex TFX$2.73B2025
Mirum Pharmaceuticals MIRM$319.45M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on LGND

Ligand Pharmaceuticals, figure by figure

Ligand Pharmaceuticals (LGND) overview: price, valuation and scorecardAll health care companies by market value

Ligand Pharmaceuticals total debt: questions and answers

How much debt does Ligand Pharmaceuticals have?

Ligand Pharmaceuticals (LGND) carried total debt of $451.49M at the end of fiscal 2025 (December 31, 2025). That is 6276.1% higher than the $7.08M of fiscal 2024.

What are the highest and lowest total debt figures on record for Ligand Pharmaceuticals?

Across the 5 fiscal years on record (2012–2025), the highest was $451.49M in fiscal 2025 and the lowest $6.17M in fiscal 2023.

How does Ligand Pharmaceuticals's debt compare with its equity?

Total debt was 0.4× shareholders' equity at the end of fiscal 2025.

How is Ligand Pharmaceuticals's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ligand Pharmaceuticals (LGND) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/LGND/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.